Imperial College London Diabetes Centre (ICLDC) and the International Consortium for Health Outcomes Management (ICHOM) collaborate to develop a standard set of outcomes that matter most to people with type-2 diabetes.

For the next 12 months, ICLDC will share medical expertise to support the initiative.

Collaborative work between the two organizations will begin in May 2017

Abu Dhabi-UAE: 19 April 2017 

Imperial College London Diabetes Centre, part of Mubadala’s network of healthcare providers, and Abu Dhabi’s one-stop-shop for the treatment, prevention, education and research of diabetes, has announced a new partnership with the International Consortium for Health Outcomes Measurement (ICHOM). The partnership will champion value-based healthcare through the creation of a global standard for diabetes management with a focus on quality of life outcomes for patients. ICLDC and ICHOM will commence their collaborative work this May.

The objective of the new partnership is the development of a standard set of health outcomes, focused on results that matter most to type-2 diabetes patients. The standard sets will serve as a reliable source of data for physicians who can then use the data and incorporate into a patient’s diabetes management plan.

For patients, ‘value-based’ healthcare means safe, appropriate, and effective care with enduring results, at a reasonable cost. For healthcare providers, the system means employing evidence-based medicine and proven treatments and techniques that take into account the patients’ wishes and preferences, as opposed to more traditional approaches to healthcare that often prioritize quotas over outcomes.

Mazen Al Dahmani, Deputy Chief Executive Officer at Imperial College London Diabetes Centre, said, “We are delighted to announce our latest partnership with ICHOM, an initiative that supports the delivery of value-based healthcare as we establish a global standard for type-2 diabetes management.  At ICLDC we are at the forefront developing a value-based approach that has the potential for positive change in clinical practices. The partnership arrangement enables us to pool our resources and expertise for the best possible outcome, and is aligned with wider global and regional initiatives in healthcare.”

ICHOM’s President, Dr. Christina Akerman said, ‘’ICHOM is very pleased to have the support of Imperial College London Diabetes Centre on this important initiative. The partnership reflects the commitment of both parties to outcomes measurement as a means of driving value in healthcare and the development of a standard set of outcomes that are meaningful to patients with type-2 diabetes.’’

For further information about the project and Imperial College London Diabetes Centre’s sponsorship, please visit http://www.ichom.org/medical-conditions/diabetes / and http://www.ichom.org/sponsoring-partners / 

-Ends-

For media enquiries and unique opportunities with doctors for interview, please contact:
Karen Gregory
Account Manager, APCO Worldwide
(m) +971.55.7802493
kgregory@apcoworldwide.com

Karen Morrison
Account Director, APCO Worldwide
(m) +971.52.863.1680
KMorrison@apcoworldwide.com

About Imperial College London Diabetes Centre
Imperial College London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility that specializes in diabetes treatment, research, training and public health awareness.

The Centre was established in Abu Dhabi by Mubadala Healthcare, in partnership with the UK’s Imperial College London, in 2006 to address the growing demand for diabetes care in the UAE. A second facility in Al Ain opened in 2011. Together, the Centres have offered diabetes prevention, education and treatment to more than to more than 800,000 patient contacts.

‘Diabetes-Knowledge-Action’ is Imperial College London Diabetes Centre’s award-winning public health awareness campaign. It was launched in 2007 under the patronage of Her Highness Sheikha Fatima bint Mubarak.

Imperial College London Diabetes Centre holds the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) in Diabetes Management and JCI Accreditation for Ambulatory Care, awarded in 2010 and again in 2013. The 2010 award made Imperial College London Diabetes Centre the only healthcare provider worldwide to hold both certifications and the first facility in the Middle East and third globally to hold JCI’s highly-acclaimed CCPC specifically for the clinical management of diabetes.

For more information log on to www.icldc.ae

About ICHOM
The International Consortium for Health Outcomes Measurement (ICHOM) was founded in 2012 by leaders at Harvard Business School, the Boston Consulting Group, and the Karolinska Institute to catalyse the global development of value-based health care. To support the move towards value, ICHOM defines “Standard Sets,” standard measures by condition or population sub-group, of essential outcomes and case-mix factors. Standard Sets include a combination of patient-reported and clinical measures and are developed through the volunteer contributions of clinical experts and patient advocates globally. ICHOM has developed 21 Standard Sets so far, covering 45% of the disease burden in advanced economies.

For more information log on to www.ichom.org

© Press Release 2017